Skip to content
SFB-Pharma

SFB-Pharma

  • Office
  • Contact
  • About Us
Posted on 7 January 20207 January 2020 by Christine Laroche

Bienvenue dans – Welkom bij:

Bienvenidos en – Welcome to:

SFB-Pharma

If you want to reach me please send a message to:

Christine Laroche  claroche@sfb-pharma.com

Recent Posts

  • (no title)

Archives

  • January 2020

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

RSS Drugs.com – New Drug Approvals

  • FDA Approves Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the Treatment of Asthma
  • FDA Approves Qdolo (tramadol hydrochloride) Oral Solution for the Management of Severe Pain
  • FDA Approves Detectnet (copper Cu 64 dotatate injection) Positron Emission Tomography (PET) Agent
  • FDA Approves Gavreto (pralsetinib) for the Treatment of Adults With Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

RSS Pharma Manufacturing News

  • Santen and US ophthalmic company Eyevance enter into share purchase agreement
  • AstraZeneca acquires Dogma’s oral PCSK9 inhibitor programme
  • Moderna, Chiesi collaborate to develop mRNA therapeutics for pulmonary arterial hypertension

SFB-Pharma Info

  • About Us
  • Contact
  • Office

RSS White papers and Web seminars

  • How to Invest in Telehealth Infrastructure for Life Beyond COVID-19
  • Enabling AI-Powered Clinical Decision Support: View from the “C” Seats
  • As the Health Industry Races COVID-19, Data Security Must Keep Up
  • Cloud Computing Clears the Way for COVID-19 Response
Proudly powered by WordPress
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok